Skip to main content

and
  1. Article

    Open Access

    AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells

    Acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) has been a major obstacle in the treatment of non-small cell lung cancer (NSCLC) patients. AXL has been reported t...

    Donghwa Kim, Duc-Hiep Bach, Yan-Hua Fan, Thi-Thu-Trang Luu in Cell Death & Disease (2019)